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A B S T R A C T
Adenoid cystic carcinoma (ACC) of the Bartholin gland is a rare gynaecological entity. Despite its slow growth
and inconspicuous presentation, vulvar ACC has a propensity for perineural invasion and is therefore associated
with high local recurrence rates.
We report a case of vulvar ACC in a 61-year-old woman with a prolonged swelling of the Bartholin gland. This
patient presented with pulmonary metastases at the moment of histological diagnosis. The vulvar and the
pulmonary lesions showed identical histology. Despite a history of human papilloma virus (HPV)-related usual
type vulvar intra-epithelial neoplasia and cervical squamous cell carcinoma, the vulvar ACC was negative for
both p16 immunohistochemistry and HPV-DNA.
We conclude that HPV is not involved in the pathogenesis of pure ACC of the Bartholin gland. Additionally,
we advocate a low threshold for performing biopsies of vulvar swellings in women aged>40 years, to rule out
malignancy and to prevent diagnostic delays.
1. Introduction
Adenoid cystic carcinoma (ACC) is a rare variant of an adeno-
carcinoma, which can arise in any organ with seromucinous or sweat
glands. Although most common in the major and minor salivary glands,
ACC has also been reported to occur in the skin, the lacrimal glands, the
breast, the oesophagus, the upper and lower respiratory tract and the
female genital tract [1–3]. In the vulva, ACC usually originates from the
Bartholin gland [3]. Primary carcinomas of the Bartholin gland account
for less than 5 % of all vulvar carcinomas and less than 1 % of all female
genital tract malignancies [4,5]. ACC represents around 30 % of Bar-
tholin gland tumours and is therefore a rare gynaecological entity [4].
Although slowly growing, vulvar ACC is notorious for its high local
recurrence rates, due to the propensity for extensive perineural invasion
[4]. Because of its rarity, slow growth and non-specific symptoms, the
possibility of an ACC is often not considered and therefore the diagnosis
is frequently delayed. Here, we report a case of vulvar ACC in a 61-year-
old woman with a history of human papilloma virus (HPV)-related
disease. We provide a brief overview of the relevant literature regarding
the association between ACC and HPV, and we discuss the lessons
learnt from this case.
1.1. Case history
A 61-year-old woman presented with pain in the right vulvovaginal
area. Upon clinical examination, a mobile, tender swelling of less than
one centimetre in size was detected on the right labium majus. The skin
overlying the vulvar swelling was intact. A provisional diagnosis of a
cyst of the Bartholin gland was established. The patient had a history of
a squamous cell carcinoma of the cervix (T2bN0) and usual type vulvar
intra-epithelial neoplasia (uVIN). Both of these lesions showed diffuse,
strong block-positivity with p16 immunohistochemistry, establishing
an association with HPV. The cervical squamous cell carcinoma had
been treated with a conisation and chemoradiotherapy. Topical imi-
quimod had been administered for the uVIN lesion. The patient had
been disease-free for four years.
After the initial presentation with vulvar pain, the patient was fol-
lowed up for ten months. Finally, a simple excision of the right
Bartholin gland was performed because of persistent pain and pro-
tracted vulvar swelling. A poorly circumscribed solid mass was re-
moved, devoid of any cysts. Histopathological examination of the spe-
cimen revealed an ACC with a predominantly cribriform growth pattern
and extensive perineural invasion (Fig. 1A-1B). Lympho-vascular space
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invasion was not observed. The tumour consisted of small glandular
lumens and larger pseudo-glandular spaces filled with periodic acid-
Schiff-positive basement membrane material. The lining cells of these
glandular spaces had predominantly monomorphic nuclei, with scant
mitotic figures. Both the glandular and pseudo-glandular spaces were
surrounded by bland-looking myoepithelial cells, which stained posi-
tive with p63 immunohistochemistry (Fig. 1C). Normal glandular
structures could not be identified in the excision, and the entire Bar-
tholin gland seemed to be replaced by the tumour.
Since this patient had a history of HPV-related gynaecological dis-
ease, p16 immunohistochemistry and molecular HPV-genotyping
(SPF10-Deia/LiPA, Laboratory BioMedical Products, Rijswijk, The
Netherlands) were performed. The ACC showed patchy non-diffuse
p16-staining (Fig. 1D), which was regarded as non-specific. The HPV-
polymerase chain reaction was also negative. Histologically, the exci-
sion was incomplete. Targeted next-generation sequencing did not re-
veal any potentially pathogenic mutations in mutation hotspots in
AKT1 (exon 3), ALK (20, 22–25), APC (14), ARAF (7), BRAF (11, 15),
CTNNB1 (3, 7, 8), EGFR (18–21), EZH2 (16), FBWX7 (9, 10), FOXL2 (1),
FGFR1 (4, 7, 12), FGFR2 (7, 9, 12), FGFR3 (7, 9), GNA11 (4, 5), GNAQ
(4, 5), GNAS (8, 9), HER2 (19–21), HRAS (2–4), IDH1 (4), IDH2 (4), KIT
(8, 9, 11, 13, 14, 17), KRAS (2–4), MAP2K1 (2, 3), MET (2, 14, 19),
MYD88 (5), NOTCH1 (26, 27), NRAS (2–4), PDGFRA (12, 14, 18),
PIK3CA (10, 21), POLD1 (12), POLE (9, 13), RAF1 (7), RET (11, 16),
RNF43 (3, 4, 9), ROS1 (38, 41), SMAD4 (3, 9, 12) and STK11 (4, 5, 8).
The genes CDKN2A, PTEN and TP53 were also sequenced, with a
coverage of 98 %, 94 % and 100 %, respectively, and did not reveal any
mutations.
A dissemination test by computed tomography showed three nod-
ular lesions (size 12−14mm) in the lungs (Fig. 2). One peripherally
located pulmonary lesion was biopsied, which showed a tumour with
similar morphology to the vulvar ACC. Immunohistochemistry for
thyroid transcription factor 1 (TTF-1) was negative (Fig. 1E-F). Given
the initial presentation of a vulvar swelling with intact overlying skin,
the morphological similarities between the vulvar and the pulmonary
lesions, the complete replacement of the Bartholin gland by the tumour,
and the lack of evidence for a primary ACC elsewhere, the final diag-
nosis of a primary Bartholin gland ACC with pulmonary metastasis was
established.
2. Discussion
This case history illustrates that an early diagnosis of ACC of the
Bartholin gland is often hampered by its inconspicuous presentation.
Because of the slow growth, the rarity and the lack of specific symp-
toms, ACCs of the Bartholin gland are often initially mistaken for cysts.
Due to the delayed diagnosis, patients with vulvar ACC often present
with locally advanced disease [3]. ACC of the Bartholin gland can in-
vade the vaginal wall, ischio-rectal fossa, and even the pubic bone,
which often prevents complete surgical removal of the lesion [6]. In
Fig. 1. Adenoid cystic carcinoma of the
Bartholin gland (A-D) with associated pul-
monary metastasis (E-F). A. Cribriform growth
pattern with extensive perineural invasion
(haematoxylin/eosin (HE) stain, original mag-
nification 100x). B. Dual cell population within
ACC (HE stain, original magnification 200x).
C. Myoepithelial cells staining positive for p63
(original magnification 100x). D. Patchy p16
positivity in the ACC (original magnification
100x). E. Biopsy from a lung nodule showed a
morphology similar to the vulvar ACC (original
magnification 40x). F. Immunohistochemistry
for TTF-1 is negative in the metastasis and
positive in the surrounding lung tissue (ori-
ginal magnification 100x).
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retrospect, the vulvar pain reported by this patient was likely caused by
perineural invasion.
Despite its rarity, a neoplasm of the Bartholin gland is an important
differential diagnosis to consider in women presenting with a Bartholin
gland mass, especially when aged over 40. Most vulvar ACCs occur in
postmenopausal women, and reported median age varies from 49 to 59
years [5,6]. We therefore advocate a low threshold for performing a
biopsy of vulvar swellings in women aged over 40. In the case of a
benign cyst, the contents will be evacuated by the biopsy and symptoms
may wane. In the case of a neoplasm, a definite diagnosis will probably
be rendered, enabling a wide local excision to minimize the risk of local
recurrence. Even when excision appears complete, an ACC is char-
acterized by a high risk of local recurrence, as well as late distant
metastases [7]. This is probably due to its tendency for extensive
perineural invasion, combined with delayed diagnosis [8]. Where there
is local recurrence or inoperable locally advanced disease, radiotherapy
can be considered to slow down progression [6].
Patients with ACC of the Bartholin gland generally survive for many
years, even in the presence of repeated local recurrence and/or distant
metastases [2,4,6]. Distant metastases are often pulmonary due to
haematogenous spread [2], as was the case in the patient reported
herein. Both the vulvar and the pulmonary lesions showed similar
histology. The pulmonary lesion did not show nuclear expression of
TTF-1. Although rare cases of primary pulmonary ACCs with weak to
moderate nuclear TTF-1 staining have been reported, most primary
pulmonary ACCs are TTF-1 negative [9]. We therefore consider TTF-1
immunohistochemistry not helpful in the differential diagnosis between
primary pulmonary ACC and pulmonary metastases.
The location of the pulmonary lesion(s), however, can aid in this
differential, as primary pulmonary ACCs are more commonly located
near the trachea or the bronchi than in the pulmonary parenchyma [9].
Since the patient described herein presented with a single vulvar
swelling with protracted course, as well as three peripherally located
pulmonary lesions, a primary pulmonary ACC with a solitary vulvar
metastasis seemed unlikely. We therefore concluded she had a primary
vulvar ACC with pulmonary metastases, in concordance with the di-
agnostic criteria applied by Cardosi et al. [10]. Interestingly, targeted
next-generation sequencing did not reveal any potentially pathogenic
mutations in mutation hot spots of a panel of commonly mutated genes
in many different types of carcinomas. Gain-of-function mutations in
the NOTCH1 gene have recently been described as being associated
with poor outcome in patients with an adenoid cystic carcinoma [11],
but NOTCH1 mutations were lacking in the tumour of this patient.
Since this patient had a history of HPV-related carcinoma, we in-
vestigated whether the ACC of the Bartholin gland was HPV-related.
The tumour showed patchy non-diffuse p16-staining and was therefore
considered p16-negative. Molecular analysis for HPV was also negative.
To our knowledge, pure ACCs of the Bartholin gland are consistently
reported to be negative for high risk-HPV [12,13]. They present a
variable expression of p16, but never diffuse block-positivity [12].
Positivity for p16 and HPV has been described in squamous cell carci-
nomas or small cell carcinomas of the cervix showing areas of ACC-like
differentiation or association with low-grade adenoid basal tumours
[12,14]. Pure ACCs of the cervix, however, have been reported to
harbour high risk HPV [15].
Associations with HPV have also been reported for carcinomas with
ACC-like differentiation of the sinonasal tract, and this entity has been
named ‘HPV-related carcinoma with ACC-like features of the sinonasal
tract’ [16]. More recently, this entity was renamed as ‘HPV-related
multi-phenotypic sinonasal carcinoma’, as it was acknowledged that the
histological spectrum of this HPV-related lesion is much broader than
ACC-like morphology alone [17]. Pure ACCs from the Bartholin gland
and elsewhere, are known to harbour translocations of theMYB,MYBL1
and NFIB genes, resulting in the novel oncogenic fusion proteins MYB-
NFIB and MYBL1-NFIB [13,16]. Unfortunately, these molecular ana-
lyses are not available at our centre and therefore this information is
lacking for the ACC reported herein. Interestingly, these translocations
have not been observed in ‘HPV-related multi-phenotypic sinonasal
carcinomas’, indicating that these tumours have a different pathogen-
esis than ‘true’ ACCs and represent a distinct entity [16].
3. Conclusion
The unexpected diagnosis of an ACC of the Bartholin gland in a 61-
year-old illustrates that vulvar swellings in women over 40 should
prompt a biopsy to rule out a malignancy. Since carcinomas may mimic
a benign cyst of the Bartholin gland, a low threshold for performing
biopsies could prevent delays in diagnosis. Additionally, this case cor-
roborates the hypothesis that HPV does not play a role in the patho-
genesis of pure ACC of the Bartholin gland.
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